S G Vienberg1, S H Jacobsen2,3, D Worm2, L E Hvolris4, L Naver4, T Almdal2, D L Hansen2, B S Wulff1, T R Clausen1, S Madsbad2, J J Holst3,5, B Andersen1. 1. Department of Diabetes and Obesity Biology, Novo Nordisk A/S, Maaloev, Denmark. 2. Department of Endocrinology, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark. 3. NNF Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 4. Department of Surgical and Medical Gastroenterology, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark. 5. Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Abstract
OBJECTIVE: The positive metabolic outcome of Roux-en-Y gastric bypass (RYGB) surgery may involve fibroblast growth factor 21 (FGF21), in both the fasting state and postprandially. We measured the fasting levels of FGF21 before and after bariatric surgery as well as the postprandial FGF21 responses after a glucose load and after a mixed meal. DESIGN: Observational intervention trial. PATIENTS AND MEASUREMENTS: Eight obese, nondiabetic patients underwent RYGB. Plasma FGF21 was measured both before and after surgery on three different days during oral glucose loads (25 g or 50 g glucose) or a mixed meal. Blood samples were taken right before the meal and at 15-min intervals until 90 min and at 150 min and 210 min relative to the start of the meal. RESULTS: Overall, fasting plasma FGF21 did not change significantly before and after surgery (262 ± 71 vs 411 ± 119 pg/ml), but for three subjects, fasting plasma FGF21 increased significantly after surgery. Furthermore, FGF21 levels increased significantly at t = 90 and t = 150 min in response to 50 g glucose, but not after a mixed meal. CONCLUSIONS: In conclusion, the observed increase in postprandial plasma FGF21 in response to glucose and the lack of FGF21 response to a mixed meal may have important implications for the physiologic role of FGF21. The increase in postprandial FGF21 in response to glucose in the early postoperative period may contribute to the metabolic improvements observed after gastric bypass.
OBJECTIVE: The positive metabolic outcome of Roux-en-Y gastric bypass (RYGB) surgery may involve fibroblast growth factor 21 (FGF21), in both the fasting state and postprandially. We measured the fasting levels of FGF21 before and after bariatric surgery as well as the postprandial FGF21 responses after a glucose load and after a mixed meal. DESIGN: Observational intervention trial. PATIENTS AND MEASUREMENTS: Eight obese, nondiabeticpatients underwent RYGB. Plasma FGF21 was measured both before and after surgery on three different days during oral glucose loads (25 g or 50 g glucose) or a mixed meal. Blood samples were taken right before the meal and at 15-min intervals until 90 min and at 150 min and 210 min relative to the start of the meal. RESULTS: Overall, fasting plasma FGF21 did not change significantly before and after surgery (262 ± 71 vs 411 ± 119 pg/ml), but for three subjects, fasting plasma FGF21 increased significantly after surgery. Furthermore, FGF21 levels increased significantly at t = 90 and t = 150 min in response to 50 g glucose, but not after a mixed meal. CONCLUSIONS: In conclusion, the observed increase in postprandial plasma FGF21 in response to glucose and the lack of FGF21 response to a mixed meal may have important implications for the physiologic role of FGF21. The increase in postprandial FGF21 in response to glucose in the early postoperative period may contribute to the metabolic improvements observed after gastric bypass.
Authors: Lydia-Ann L S Harris; Gordon I Smith; Bettina Mittendorfer; J Christopher Eagon; Adewole L Okunade; Bruce W Patterson; Samuel Klein Journal: J Clin Endocrinol Metab Date: 2017-10-01 Impact factor: 5.958
Authors: Jakub Poloczek; Wojciech Kazura; Ewa Kwaśnicka; Janusz Gumprecht; Jerzy Jochem; Dominika Stygar Journal: J Diabetes Res Date: 2021-08-06 Impact factor: 4.011
Authors: Mette S Nielsen; Susanna Søberg; Julie B Schmidt; Anne Chenchar; Anders Sjödin; Matthew P Gillum Journal: PeerJ Date: 2021-04-14 Impact factor: 2.984
Authors: Mette S Nielsen; Christian Ritz; Anne Chenchar; Wender L P Bredie; Matthew P Gillum; Anders Sjödin Journal: Nutrients Date: 2021-10-28 Impact factor: 5.717
Authors: Thomas P J Solomon; Steven Carter; Jacob M Haus; Kristian Karstoft; Stephanie von Holstein-Rathlou; Mette S Nielsen; Matthew P Gillum Journal: PeerJ Date: 2022-01-19 Impact factor: 2.984